Skip to main navigation

*

Client nav

About Arcturus

RNA Medicines

Technologies

Pipeline

Platforms

Business Development

Publications

Investor Relations

Media Coverage

Categories

Year

BioCentury “Self-amplifying may be the next frontier in RNA therapies”

March 19, 2021

Nature “How COVID unlocked the power of RNA vaccines”

January 12, 2021

Pharma’s Almanac “How COVID-19 Is Reshaping Vaccine Development: Innovations in…

December 9, 2020

Arcturus Therapeutics Nasdaq Tower 3rd Anniversary 1.2 MB

November 16, 2020

Arcturus Therapeutics’ multicultural team describes (in many different language…

November 4, 2020

Bloomberg “Coronavirus Daily One-Shot Wonders”

October 10, 2020

Bloomberg “Hedge Fund-Pick Arcturus Gambles on a One-Shot Covid Vaccine”

October 8, 2020

The Sophia Consulting Firm “Amplifying Scientific Innovation with Joseph Payne,…

October 8, 2020

The Straits Times “Firm behind Singapore's potential vaccine to test freeze-dri…

October 8, 2020

Biospace “Arcturus CEO: Investigational COVID-19 Vaccine Could Play Notable Rol…

September 23, 2020

Pagination

Current page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Next page
Last page

Displaying 1 - 10 of 76

Arcturus-Covid19 Message.jpg

Nasdaq combined

Investor Home

Corporate Governance

Governance Highlights
Management Team
Board of Directors
Committee Composition

Financials & Filings

SEC Filings
Annual Reports
Quarterly Results

News & Events

Press Releases
Videos
Media Coverage
Presentations
Events

Stock Information

Stock Quote
Historical Price Lookup
Analyst Coverage

Investor Resources

Investor FAQ
Contact IR
Email Alerts

Home
Contact
Careers
Legal

© 2021 Arcturus Therapeutics, Inc.

Search